ApprovalTrail

Approval · Notice of Compliance 11548 · 2010

RAN-FENTANYL MATRIX PATCH: Notice of Compliance 11548

Issued June 21, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
11548
Date
June 21, 2010
Company
Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to an Abbreviated New Drug Submission (SANDS), supplement
Submission class
Admin
Reason
Revised Product Monograph
Therapeutic class
Opioid analgesic
Canadian reference product
DURAGESIC (Janssen-Ortho Inc.)

Products in this notice

BrandDINStatus today
RAN-FENTANYL MATRIX PATCHNot yet assigned—

Medicinal ingredients